首页
>>
产品中心
>>
蛋白产品
>>
重组蛋白
>
Mouse DLL4 Protein, mFc Tag

Mouse DLL4 Protein, mFc Tag

产品编号

KMP3945

别名

三角洲样典型Notch配体4, DLL4 Protein, Mouse DLL4 Protein, mFc Tag

规格
  • 50ug
  • 100ug
  • 200ug
产品介绍
Alias三角洲样典型Notch配体4, DLL4 Protein, Mouse DLL4 Protein, mFc Tag
Catalog NumberKMP3945
Product DescriptionThe Mouse DLL4 Protein(KMP3945) is produced in HEK293 Cells. A DNA sequence encoding the Mouse PVR (NP_062327.2) (Met1-Pro525) is expressed with the Fc region of Mouse IgG2a at the C-terminus.
Molecular NameDLL4
SpeciesMouse
HostHEK293 Cells
Size50ug, 100ug, 200ug
Purity>90% as determined by SDS-PAGE
PurificationAffinity purification
Endotoxin<1.0 EU/ug determined by the LAL method
FormulationPBS, pH7.4
BackgroundDelta-like protein 4 (DLL4, Delta4), a type I membrane-bound Notch ligand, is one of five known Notch ligands in mammals and interacts predominantly with Notch 1, which has a key role in vascular development. Recent studies yield substantial insights into the role of DLL4 in angiogenesis. DLL4 is induced by vascular endothelial growth factor (VEGF) and acts downstream of VEGF as a 'brake' on VEGF-induced vessel growth, forming an autoregulatory negative feedback loop inactivating VEGF. DLL4 is downstream of VEGF signaling and its activation triggers a negative feedback that restrains the effects of VEGF. Attenuation of DLL4/Notch signaling results in chaotic vascular network with excessive branching and sprouting. DLL4 is widely distributed in tissues other than vessels including many malignancies. Furthermore, the molecule is internalized on binding its receptor and often transported to the nucleus. In pathological conditions, such as cancer, DLL4 is up-regulated strongly in the tumour vasculature. Blockade of DLL4-mediated Notch signaling strikingly increases nonproductive angiogenesis, but significantly inhibits tumor growth in preclinical mouse models. In preclinical studies, blocking of DLL4/Notch signaling is associated with a paradoxical increase in tumor vessel density, yet causes marked growth inhibition due to functionally defective vasculature. Thus, DLL4 blockade holds promise as an additional strategy for angiogenesis-based cancer therapy.
Storage ConditionAliquot and store at -20℃ to -80℃. Avoid repeated freezing and thawing cycles.
Shipping ConditionIn general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature. If supplied as liquid, the proteins will be shipped with dry ice.
Molecular Weight80.61 kDa

登录

还没有账号?立即注册

注册

已有账号?立即登录

立即询价